Wed26 Opening plenary: Transforming diabetes care: National perspective on hybrid closed loop implementation and equity Start time: 09:20 am End time: 10:40 am Hall 5 Chair: Clare Hambling, Norfolk Fulya Mehta, Liverpool Dita Aswani, Sheffield Charlotte Boughton, Cambridge Brian Kennon, Scotland Partha Kar, Portsmouth Colette Marshall, Diabetes UK Jenni Minto, Scottish Government Opening words Start time: 9:00 am End time: 9:10 am Colette Marshall, Diabetes UK Welcome address Start time: 9:10 am End time: 9:20 am Jenni Minto, Scottish Government Opening comments Start time: 9:20 am End time: 9:25 am Clare Hambling, Norfolk Fulya Mehta, Liverpool Interim GIRFT report for children and young people's services: Technology challenges and wins Start time: 9:25 am End time: 9:45 am Dita Aswani, Sheffield Pumps and hybrid closed loop in type 2 diabetes: The research Start time: 9:45 am End time: 10:00 am Charlotte Boughton, Cambridge Equity in action: Scotland's journey to universal hybrid closed loop access Start time: 10:00 am End time: 10:20 am Brian Kennon, Scotland From disparities to access: Diabetes technology to boldly go Start time: 10:20 am End time: 10:40 am Partha Kar, Portsmouth
Opening comments Start time: 9:20 am End time: 9:25 am Clare Hambling, Norfolk Fulya Mehta, Liverpool
Interim GIRFT report for children and young people's services: Technology challenges and wins Start time: 9:25 am End time: 9:45 am Dita Aswani, Sheffield
Pumps and hybrid closed loop in type 2 diabetes: The research Start time: 9:45 am End time: 10:00 am Charlotte Boughton, Cambridge
Equity in action: Scotland's journey to universal hybrid closed loop access Start time: 10:00 am End time: 10:20 am Brian Kennon, Scotland
From disparities to access: Diabetes technology to boldly go Start time: 10:20 am End time: 10:40 am Partha Kar, Portsmouth
Wed26 Banting Memorial Lecture Start time: 10:40 am End time: 11:20 am Hall 5 Chair: Kamlesh Khunti, Leicester Jonathan Valabhji, London Aligning clinical practice, policy and research Start time: 10:40 am End time: 11:20 am Jonathan Valabhji, London
Aligning clinical practice, policy and research Start time: 10:40 am End time: 11:20 am Jonathan Valabhji, London
Wed26 Leading self: Leadership in complex healthcare environments Start time: 10:40 am End time: 11:20 am Dochart Chair: Sarah Alicea, London
Wed26 Facilitated posters: Psychological care Start time: 10:40 am End time: 11:20 am Poster theatre (Exhibition Hall)
Wed26 Newly Diagnosed with type 2 takeover Start time: 11:20 am End time: 11:50 am Poster theatre (Exhibition Hall)
Wed26 Diabetes UK Primary Care Poster Award Start time: 11:20 am End time: 11:50 am Poster theatre (Exhibition Hall)
Wed26 Preparing the UK for early detection and treatment of type 1 diabetes Start time: 11:50 am End time: 01:10 pm Lomond Chair: Rachel Besser, Oxford Kathleen Gilllespie Parth Narendran Update on screening efforts on type 1 diabetes Start time: 11:50 am End time: 12:10 pm Parth Narendran, Birmingham
Update on screening efforts on type 1 diabetes Start time: 11:50 am End time: 12:10 pm Parth Narendran, Birmingham
Wed26 Diabetes UK Education and Self-management Award Start time: 11:50 am End time: 12:50 pm Boisdale
Wed26 Diabetic Medicine symposium: Early onset type 2 diabetes in pregnancy and preconception Start time: 11:50 am End time: 12:50 pm Lomond Chair: Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London Sharon Mackin, Glasgow Danielle Schoenaker, Southampton Sara White, London Uncharted territory: What can we learn about type 2 diabetes in pregnancy from Scottish data? Start time: 11:50 am End time: 12:05 pm Sharon Mackin, Glasgow Preconception care in type 2 diabetes: Evidence to practice Start time: 12:05 pm End time: 12:20 pm Danielle Schoenaker, Southampton Pregnancy care in type 2 diabetes: What is the current landscape and where are we heading? Start time: 12:20 pm End time: 12:30 pm Sara White, London Debate and the panel discussion to inform consensus statement Start time: 12:30 pm End time: 12:50 pm Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London
Uncharted territory: What can we learn about type 2 diabetes in pregnancy from Scottish data? Start time: 11:50 am End time: 12:05 pm Sharon Mackin, Glasgow
Preconception care in type 2 diabetes: Evidence to practice Start time: 12:05 pm End time: 12:20 pm Danielle Schoenaker, Southampton
Pregnancy care in type 2 diabetes: What is the current landscape and where are we heading? Start time: 12:20 pm End time: 12:30 pm Sara White, London
Debate and the panel discussion to inform consensus statement Start time: 12:30 pm End time: 12:50 pm Robert Lindsay, Glasgow Claire Meek, Leicester Nick Oliver, London
Wed26 Preparing the UK for early detection and treatment of type 1 diabetes Start time: 11:50 am End time: 01:20 pm Hall 5 Chair: Kathleen Gillespie, Bristol Susan Wong, Cardiff Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States Update on screening efforts on type 1 diabetes Start time: 11:50 am End time: 12:10 pm Parth Narendran, Birmingham Managing screen detected type 1 diabetes Start time: 12:10 pm End time: 12:30 pm Rachel Besser, Oxford Delaying the need for insulin Start time: 12:30 pm End time: 12:50 pm Colin Dayan, Cardiff Real-world US experience with teplizumab for type 1 diabetes prevention Start time: 12:50 pm End time: 1:10 pm Kimber Simmons, Colorado, United States Facilitated discussion Start time: 1:10 pm End time: 1:20 pm Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States
Update on screening efforts on type 1 diabetes Start time: 11:50 am End time: 12:10 pm Parth Narendran, Birmingham
Managing screen detected type 1 diabetes Start time: 12:10 pm End time: 12:30 pm Rachel Besser, Oxford
Real-world US experience with teplizumab for type 1 diabetes prevention Start time: 12:50 pm End time: 1:10 pm Kimber Simmons, Colorado, United States
Facilitated discussion Start time: 1:10 pm End time: 1:20 pm Parth Narendran, Birmingham Rachel Besser, Oxford Colin Dayan, Cardiff Kimber Simmons, Colorado, United States
Wed26 Predicting and preventing diabetes related cardiometabolic diseases and complications: Reviews of current evidence, guidelines and recommendations for early detection and management of heart, liver and kidney disease Start time: 11:50 am End time: 01:20 pm Alsh Chair: Ahmad Moolla, London Ameet Bakhai, London Guru Aithal, Nottingham David Wheeler, London Cardiac co-morbidity in people living with diabetes: Review of evidence for screening for cardiac disease and the benefits of prompt intervention Start time: 11:50 am End time: 12:15 pm Ameet Bakhai, London Metabolic associated steatotic liver disease, a review of latest best practice and guidelines for screening and management in patients with diabetes Start time: 12:15 pm End time: 12:40 pm Guru Aithal, Nottingham Multidisciplinary and specialist care provision in diabetes and renal disease, the benefits of early intervention and judicious management Start time: 12:40 pm End time: 1:05 pm Guru Aithal, Nottingham Panel discussion on multidisciplinary working in diabetes care Start time: 1:05 pm End time: 1:20 pm Ameet Bakhai, London Guru Aithal, Nottingham David Wheeler, London
Cardiac co-morbidity in people living with diabetes: Review of evidence for screening for cardiac disease and the benefits of prompt intervention Start time: 11:50 am End time: 12:15 pm Ameet Bakhai, London
Metabolic associated steatotic liver disease, a review of latest best practice and guidelines for screening and management in patients with diabetes Start time: 12:15 pm End time: 12:40 pm Guru Aithal, Nottingham
Multidisciplinary and specialist care provision in diabetes and renal disease, the benefits of early intervention and judicious management Start time: 12:40 pm End time: 1:05 pm Guru Aithal, Nottingham
Panel discussion on multidisciplinary working in diabetes care Start time: 1:05 pm End time: 1:20 pm Ameet Bakhai, London Guru Aithal, Nottingham David Wheeler, London
Wed26 Neurodivergence and diabetes: What is it, who does it affect and how can i help? Start time: 11:50 am End time: 01:20 pm Dochart Chair: Rose Stewart, Wrexham Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich Opening comments Start time: 11:50 am End time: 11:55 am Rose Stewart, Wrexham Introduction to neurodivergence Start time: 11:55 am End time: 12:10 pm Vicky Mckechnie, London NHS approaches to neurodivergence Start time: 12:10 pm End time: 12:25 pm Rose Stewart, Wrexham When neurodivergence and diabetes meet Start time: 12:25 pm End time: 12:50 pm Jacqueline Allan, Norwich Clinical skills and resources for neuroaffirmative care in diabetes Start time: 12:50 pm End time: 1:10 pm Rose Stewart, Wrexham Panel questions Start time: 1:10 pm End time: 1:20 pm Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich
When neurodivergence and diabetes meet Start time: 12:25 pm End time: 12:50 pm Jacqueline Allan, Norwich
Clinical skills and resources for neuroaffirmative care in diabetes Start time: 12:50 pm End time: 1:10 pm Rose Stewart, Wrexham
Panel questions Start time: 1:10 pm End time: 1:20 pm Rose Stewart, Wrexham Vicky Mckechnie, London Jacqueline Allan, Norwich
Wed26 Technology, tools and innovation Start time: 11:50 am End time: 01:20 pm Carron Chair: Khor Benedicitine, Glasgow Adrian Heald, Manchester
Wed26 Diabetes UK Young People's Diabetes Service Award Start time: 01:30 pm End time: 02:00 pm Poster theatre (Exhibition Hall)
Wed26 Hedia & Glooko: Integrated diabetes care Start time: 01:40 pm End time: 02:00 pm Ditte Hjorth Laursen
